DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+29.78%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.06B
AUM Growth
+$3.06B
(+14%)
Cap. Flow
+$87M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
47.63%
Holding
153
New
43
Increased
25
Reduced
27
Closed
26
Top Buys
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$150M |
| 2 |
AbbVie
ABBV
|
$89.8M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$48.9M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$43.4M |
| 5 |
Larimar Therapeutics
LRMR
|
$41.6M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$216M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$129M |
| 3 |
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
|
$62.2M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$40.5M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$39.3M |
Sector Composition
| 1 | Healthcare | 61.01% |
| 2 | Financials | 2.54% |
| 3 | Technology | 0.47% |
| 4 | Industrials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASPX
1
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $446M | 14.45% | 4,449,103 +1,500,000 | +51% | +$150M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $332M | 10.76% | 12,792,689 +1,093,642 | +9% | +$28.4M |
|
|
3
AbbVie
ABBV
$372B
| $89.8M | 2.91% | +1,534,000 | New | +$89.8M |
|
|
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
| $87.8M | 2.84% | 5,073,050 +261,556 | +5% | +$4.52M |
|
|
ARRY
5
DELISTED
Array Biopharma Inc
ARRY
| $87.2M | 2.83% | 11,834,595 | – | – |
|
6
Adverum Biotechnologies
ADVM
$64.6M
| $85.8M | 2.78% | 2,117,473 +502,804 | +31% | +$20.4M |
|
|
BLUE
7
DELISTED
bluebird bio
BLUE
| $76.2M | 2.47% | 631,309 -219,623 | -26% | -$26.5M |
|
|
AVDL
8
Avadel Pharmaceuticals
AVDL
$1.43B
| $73.2M | 2.37% | 4,072,809 -1,185,666 | -23% | -$21.3M |
|
9
DaVita
DVA
$9.85B
| $59.3M | 1.92% | 730,000 +295,000 | +68% | +$24M |
|
|
INFI
10
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $55.5M | 1.8% | 3,968,155 +110,350 | +3% | +$1.54M |
|
|
UAM
11
DELISTED
Universal American Corp
UAM
| $55.4M | 1.79% | 5,186,148 -428,650 | -8% | -$4.58M |
|
|
ONCE
12
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $48.9M | 1.58% | +631,192 | New | +$48.9M |
|
|
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
| $43.4M | 1.41% | +512,800 | New | +$43.4M |
|
|
14
Larimar Therapeutics
LRMR
$310M
| $41.6M | 1.35% | +1,050,178 | New | +$41.6M |
|
|
ARNA
15
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $40.3M | 1.31% | 9,229,379 +2,275,642 | +33% | +$9.94M |
|
16
GSK
GSK
$79.9B
| $40.3M | 1.31% | 873,185 +309,885 | +55% | +$14.3M |
|
|
ELGX
17
DELISTED
Endologix Inc
ELGX
| $40.1M | 1.3% | 2,349,351 -1,029,436 | -30% | -$17.6M |
|
18
Vanda Pharmaceuticals
VNDA
$279M
| $38.4M | 1.25% | 4,134,157 -5,630 | -0.1% | -$52.4K |
|
19
Insmed
INSM
$28.8B
| $33.9M | 1.1% | 1,628,531 -613,100 | -27% | -$12.8M |
|
|
GWPH
20
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $33.1M | 1.07% | +363,700 | New | +$33.1M |
|
|
ATRS
21
DELISTED
Antares Pharma, Inc.
ATRS
| $32.7M | 1.06% | 12,078,318 +3,974,000 | +49% | +$10.8M |
|
22
eHealth
EHTH
$118M
| $30.6M | 0.99% | 3,264,588 +1,000,000 | +44% | +$9.38M |
|
|
AET
23
DELISTED
Aetna Inc
AET
| $30.3M | 0.98% | +284,300 | New | +$30.3M |
|
|
SAGE
24
DELISTED
Sage Therapeutics
SAGE
| $29.9M | 0.97% | 595,443 +332,818 | +127% | +$16.7M |
|
25
Xencor
XNCR
$580M
| $29M | 0.94% | +1,895,535 | New | +$29M |
|